Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Chubb
Colorcon
Johnson and Johnson
Fish and Richardson
US Department of Justice
McKesson
Express Scripts
Federal Trade Commission

Generated: June 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,225,596

« Back to Dashboard

Summary for Patent: 4,225,596
Title: Method for treating calcium imbalance and improving calcium absorption in mammals
Abstract:A method for treating or preventing metabolic bone disease characterized by loss of bone mass and of improving the calcium balance and calcium absorption of mammals, particularly of women in the post menopausal state, by administering at least one compound having the formulae ##STR1## where R.sub.1, R.sub.2 and R.sub.4 are each selected from the group consisting of hydrogen, hydroxyl, lower alkyl, acyl and O-alkyl and R.sub.3 is selected from the group consisting of hydrogen, hydroxyl, keto, lower alkyl, acyl and O-alkyl.
Inventor(s): DeLuca; Hector F. (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation (Madison, WI)
Application Number:05/951,320
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,225,596
Patent Claim Types:
see list of patent claims
Use; Formulation; Delivery;

Drugs Protected by US Patent 4,225,596

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Fuji
Queensland Health
Chubb
US Army
Express Scripts
Baxter
Chinese Patent Office
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.